Clinical Trial Update: Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a conditioning regimen of total-body irradiation with tacrolimus and mycophenolate mofetil followed by bone marrow transplantation in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes

Drugs mentioned

• Mycophenolate mofetil (CellCept) (mycophenolate mofetil)
• Tacrolimus (Prograf) (tacrolimus)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED